Yahoo Finance • yesterday

Sector Update: Healthcare Stocks Gain Late Afternoon

Healthcare stocks rose late Friday afternoon, with the NYSE Healthcare Index up 1.2% and the State S PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 2 days ago

Sector Update: Healthcare Stocks Gain Friday Afternoon

Healthcare stocks rose Friday afternoon, with the NYSE Healthcare Index up 1.2% and the State Street PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 4 days ago

Premarket movers: Constellation Brands tumbles, SpaceX debt plans weigh

Investing.com - U.S. stock futures pointed lower on Wednesday ahead of the release of key minutes from the Federal Reserve's latest policy gathering, as investors looked for clues on the central bank's interest-rate outlook. Before you bu... Full story

Yahoo Finance • 5 days ago

Novavax, Moderna stocks fall after WHO calls plague risk 'low'

Novavax stock (NVAX) fell on Tuesday after a World Health Organization (WHO) spokesperson told reporters that there was a "low" risk of a plague epidemic, after a 28-year-old woman who worked in a Russian anti-plague laboratory died last w... Full story

Yahoo Finance • 5 days ago

S&P 500 hovers near record highs as Treasury yields ease: AlphaCheck

Good morning. Stock extended gains after the Nasdaq Composite (^IXIC) posted a fresh record, boosted by all-time highs in Nvidia (NVDA) shares. The S&P 500 also climbed within striking distance of its own record as Treasury yields eased.... Full story

Yahoo Finance • 24 days ago

Moderna Climbs 6% as Cancer Vaccine Trade Extends a 137% Month; BioNTech and Novavax Edge Higher

Quick Read Moderna surged 5% to $152.83, extending a stunning 137% one-month run fueled solely by its Phase 2b melanoma vaccine data showing a 49% reduction in recurrence risk. BioNTech edged up just 1% despite running a rival mRNA cancer... Full story

Yahoo Finance • 25 days ago

HHS to launch autism research initiative utilizing AI: report

[A cardboard sign with the diagnosis of autism made of multicolored letters in the hands of a child on a purple background with pieces of colorful puzzles.] Maryna Auramchuk/iStock via Getty Images * HHS is expected to unveil an autism... Full story

Yahoo Finance • 26 days ago

Is Cancer the Turnaround Moderna Has Been Looking for Post-COVID?

Shares of Moderna MRNA have staged a remarkable comeback this year as investors increasingly warm to the possibility that the company can rebuild its business beyond COVID-19 vaccines. After becoming one of the biggest pandemic winners, Mo... Full story

Yahoo Finance • 26 days ago

Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know

Novavax (NVAX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the past month, shares of this vaccine maker... Full story

Yahoo Finance • 29 days ago

Moderna, 10x Genomics, Oscar Health, and Novavax Shares Are Soaring, What You Need To Know

Moderna, 10x Genomics, Oscar Health, and Novavax Shares Are Soaring, What You Need To Know What Happened? A number of stocks jumped in the morning session after Morningstar reported that challenging macroeconomic conditions across broade... Full story

Yahoo Finance • last month

3 of Wall Street’s Favorite Stocks with Open Questions

3 of Wall Street's Favorite Stocks with Open Questions Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it's important to remain skeptical because analysts face i... Full story

Yahoo Finance • last month

Vaccines Global Market Intelligence Report 2026-2035 Featuring Bio Farma, Emergent BioSolutions, GC Pharma, GlaxoSmithKline, Janssen, Merck, Novavax, Moderna, Pfizer, Sanofi Pasteur, and Valneva

Company Logo Dublin, Sept. 07, 2026 (GLOBE NEWSWIRE) -- The "Vaccines Market Distribution by Type of Vaccine API, Targeted Patient Population, Type of Vaccines, Route of Administration, and Key Geographical Region - Trends and Forecasts T... Full story

Yahoo Finance • last month

RFK Jr. is probing if U.S. troops died of COVID shots: report

[Covid-19 vaccine in a vial, immunization and treatment of infection] Kittisak Kaewchalun An Army doctor is working with Health Secretary Robert F. Kennedy Jr. and Defense Secretary Pete Hegseth to investigate whether U.S. troops died fro... Full story

Yahoo Finance • last month

Novavax (NVDA) Following Updated Nuvaxovid Approval Faces A Wide Fair Value Debate

Novavax (NVAX) drew fresh attention after announcing that partners secured approvals for an updated Nuvaxovid formulation targeting the SARS CoV 2 XFG variant for the 2026 to 2027 vaccination season. The news has arrived after a mixed per... Full story

Yahoo Finance • 2 months ago

Stocks making big moves this week: Bally's, Adobe, Novavax, Semtech, and STAAR Surgical

Stocks making big moves this week: Bally's, Adobe, Novavax, Semtech, and STAAR Surgical Check out the companies making headlines this week: Bally's (NYSE:BALY): Gaming, betting and entertainment company Bally's Corporation (NYSE:BALY) ro... Full story

Yahoo Finance • 2 months ago

HHS seeking public input on vaccine recommendation categories

[US Department of Health and Human Services] * HHS has issued a formal Request for Information that seeks public input on the categories used in federal vaccine recommendations and how shared decision-making between patients and doctors... Full story

Yahoo Finance • 2 months ago

Moderna shares double as cancer vaccine data rekindles investor hopes

By Christy Santhosh and Shashwat Chauhan Aug 19 (Reuters) - Moderna shares more than doubled on Wednesday, adding about $30 billion to its market value, after promising late-stage data on its personalized mRNA cancer ‌therapy developed wi... Full story

Yahoo Finance • 2 months ago

U.K. regulator reaffirms safety of childhood vaccination

[Syringe drawing liquid medication from medical vial] zhikun sun/iStock via Getty Images Days after President Donald Trump ordered major changes to the U.S. childhood immunization schedule, the U.K. drug regulator on Wednesday reaffirmed... Full story

Yahoo Finance • 2 months ago

Novavax (NVDA) Could Be 44% Undervalued Following Its Licensing Pivot And Cyclospora Focus

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Why Novavax's Licensing Pivot and Cyclospora Focus Matter Now Novavax (NVAX) is in the spotlight after shifting away... Full story

Yahoo Finance • 2 months ago

Novavax (NVAX) Stock Falls Amid Market Uptick: What Investors Need to Know

Novavax (NVAX) closed at $7.37 in the latest trading session, marking a -1.6% move from the prior day. This move lagged the S&P 500's daily gain of 0.21%. Meanwhile, the Dow experienced a rise of 1.03%, and the technology-dominated Nasdaq... Full story